MyGene

Guangzhou MyGene Medical Technology (MyGene) is a leading Chinese molecular diagnostics company specializing in precision oncology and personalized medicine. Founded in 2015 and headquartered in Guangzhou with a dedicated R&D center in Silicon Valley, the company develops and commercializes advanced PCR and Next-Generation Sequencing (NGS) kits for cancer diagnosis, treatment selection, and monitoring. Its flagship product is a multi-gene PCR companion diagnostic kit for non-small cell lung cancer (NSCLC), which was the first of its kind to receive NMPA approval in China. MyGene maintains a robust pipeline of diagnostic panels covering major solid tumors and has established strategic partnerships with global leaders like Illumina to advance genomic medicine and clinical precision.